JoVE Journal
Cancer Research
Cancer Research
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Chapters
Summary
Here we describe a protocol aimed at investigating the impact of aberrant splicing on drug resistance in solid tumors and hematological malignancies. To this goal, we analyzed the transcriptomic profiles of parental and resistant in vitro models through RNA-seq and established a qRT-PCR based method to validate candidate genes.